Home/Filings/4/0001415889-24-028286
4//SEC Filing

Utter Christine Marie 4

Accession 0001415889-24-028286

CIK 0001070081other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:20 PM ET

Size

18.6 KB

Accession

0001415889-24-028286

Insider Transaction Report

Form 4
Period: 2024-12-02
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Transactions
  • Sale

    Common Stock

    2024-12-02$51.34/sh2,497$128,19653,036 total
  • Exercise/Conversion

    Common Stock

    2024-12-02$51.00/sh+14,695$749,44567,123 total
  • Exercise/Conversion

    Common Stock

    2024-12-02$51.00/sh+3,105$158,35555,533 total
  • Sale

    Common Stock

    2024-12-02$52.24/sh608$31,76252,428 total
  • Sale

    Common Stock

    2024-12-02$51.53/sh9,919$511,12657,204 total
  • Sale

    Common Stock

    2024-12-02$52.45/sh4,776$250,50152,428 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-023,10514,695 total
    Exercise: $51.00Exp: 2025-01-02Common Stock (3,105 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-0214,6950 total
    Exercise: $51.00Exp: 2025-01-02Common Stock (14,695 underlying)
Footnotes (6)
  • [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.
  • [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.11 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.15 to $52.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F6]Currently exercisable.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001707685

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:20 PM ET
Size
18.6 KB